Mucin-Like Domain of Ebola Virus Glycoprotein Enhances Selective Oncolytic Actions against Brain Tumors
Xue Zhang, Tingting Zhang, John N. Davis, Andrea Marzi, Anthony M. Marchese, Michael D. Robek, Anthony N. van den Pol
Abstract
The Ebola virus glycoprotein contains a mucin-like domain which may play a role in immune evasion. Chimeric vesicular stomatitis viruses with the EBOV glycoprotein substituted for the VSV glycoprotein show greater safety and efficacy in targeting brain tumors in immunodeficient mice when the MLD was expressed within the EBOV glycoprotein than when EBOV lacked the mucin-like domain.
Topics & Concepts
Ebola virusGlycoproteinVesicular stomatitis virusBiologyVirologyMucinOncolytic virusMembrane glycoproteinsVesicular stomatitis Indiana virusGlycanVirusVesicular StomatitisImmune systemP-glycoproteinEbolavirusImmunologyMicrobiologyMolecular biologyMultiple drug resistanceAntibioticsBiochemistryViral Infections and Outbreaks ResearchVirus-based gene therapy researchHepatitis B Virus Studies